Literature DB >> 18045159

Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment.

Mounira Banasr1, Ronald S Duman.   

Abstract

Structural and morphological changes in limbic brain regions are associated with depression, chronic stress and antidepressant treatment, and increasing evidence supports the hypothesis that dysregulation of cell proliferation contributes to these effects. We review the morphological alterations observed in two brain regions implicated in mood disorders, the prefrontal cortex and hippocampus, and discuss the similarities and differences of the cellular consequences of chronic stress. We briefly discuss the proposed mechanisms implicated in neuroplasticity impairments that result from stress and that contribute to mood disorders, with a particular interest in adult neurogenesis and gliogenesis. This information has contributed to novel antidepressant medication development that utilizes adult neurogenesis and gliogenesis as preclinical cellular markers for predicting antidepressant properties of novel compounds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045159     DOI: 10.2174/187152707783220929

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  62 in total

1.  Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models.

Authors:  Heath D Schmidt; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2010-08-04       Impact factor: 7.853

2.  A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect.

Authors:  Xia Liu; Chi-Bun Chan; Sung-Wuk Jang; Sompol Pradoldej; Junjian Huang; Kunyan He; Lien H Phun; Stefan France; Ge Xiao; Yonghui Jia; Hongbo R Luo; Keqiang Ye
Journal:  J Med Chem       Date:  2010-11-12       Impact factor: 7.446

3.  Antidepressant Use in the Elderly Is Associated With an Increased Risk of Dementia.

Authors:  Chenkun Wang; Sujuan Gao; Hugh C Hendrie; Joe Kesterson; Noll L Campbell; Anantha Shekhar; Christopher M Callahan
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

4.  Oxotremorine treatment restores hippocampal neurogenesis and ameliorates depression-like behaviour in chronically stressed rats.

Authors:  J Veena; B N Srikumar; K Mahati; T R Raju; B S Shankaranarayana Rao
Journal:  Psychopharmacology (Berl)       Date:  2011-04-16       Impact factor: 4.530

Review 5.  Epigenetic choreographers of neurogenesis in the adult mammalian brain.

Authors:  Dengke K Ma; Maria Carolina Marchetto; Junjie U Guo; Guo-li Ming; Fred H Gage; Hongjun Song
Journal:  Nat Neurosci       Date:  2010-11       Impact factor: 24.884

Review 6.  Targeted electrode-based modulation of neural circuits for depression.

Authors:  Helen S Mayberg
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

7.  Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice.

Authors:  Younghyurk Lee; Hyeonwi Son; Gyeongwha Kim; Sujeong Kim; Dong Hoon Lee; Gu Seob Roh; Sang Soo Kang; Gyeong Jae Cho; Wan Sung Choi; Hyun Joon Kim
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

8.  Hippocampal changes associated with early-life adversity and vulnerability to depression.

Authors:  Uma Rao; Li-Ann Chen; Anup S Bidesi; Mujeeb U Shad; M Albert Thomas; Constance L Hammen
Journal:  Biol Psychiatry       Date:  2009-12-16       Impact factor: 13.382

9.  Eszopiclone and fluoxetine enhance the survival of newborn neurons in the adult rat hippocampus.

Authors:  Xiaowei W Su; Xiao-Yuan Li; Mounira Banasr; Ronald S Duman
Journal:  Int J Neuropsychopharmacol       Date:  2009-09-24       Impact factor: 5.176

10.  Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus.

Authors:  Xiaowei W Su; Xiao-Yuan Li; Mounira Banasr; Ja Wook Koo; Mohammed Shahid; Brian Henry; Ronald S Duman
Journal:  Psychopharmacology (Berl)       Date:  2009-07-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.